Intas Pharmaceuticals Limited   Report issue

For profit Phase 1 Phase 3
Founded: Ahmedabad India (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2018
NCT04014062
First Marketed Drug
2017
irinotecan (Camptosar)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Intas Pharmaceutical Limited (Biopharma Division) | Intas Pharmaceuticals Limited | Intas Pharmaceuticals, Ltd. | INTAS PHARMS USA